Nebenwirkungen · Lyrica
Lyrica 25 mg orodispersible tablets Lyrica 75 mg orodispersible tablets Lyrica 150 mg orodispersible tablets · Abschnitt 4.8 · PDF-Seite 43–44
HOS-112950 · Präparat HOS-093785
43 System Organ Class Adverse drug reactions Uncommon Sexual dysfunction, ejaculation delayed, dysmenorrhoea, breast pain Rare Amenorrhoea, breast discharge, breast enlargement, gynaecomastia General disorders and administration site conditions Common Oedema peripheral, oedema, gait abnormal, fall, feeling drunk, feeling abnormal, fatigue Uncommon Generalised oedema, face oedema, chest tightness, pain, pyrexia, thirst, chills, asthenia Investigations Common Weight increased Uncommon Blood creatine phosphokinase increased, blood glucose increased, platelet count decreased, blood creatinine increased, blood potassium decreased, weight decreased Rare White blood cell count decreased * Alanine aminotransferase increased (ALT) and aspartate aminotransferase increased (AST).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-10-13T14:23:00Z · SHA-256 b911bddbab432f8a0fcedb9c67537bff55e0bf53d314c31c88869bca834605af · Passage abbb7fc5e3c313498dbacef1cb63ee921331af841282d47e22a2368688723dba · Zeichen 6207–7330 im Abschnitt